Similar results were obtained for FGFR-2-IIIc, with no variation in mRNA expression for hyperplastic tissue (0.99 fold, P = 0.94) and strong decrease in adenoma (0.08 fold, P<0.01) and carcinoma (0.26 fold, P<0.01) samples (Fig. 3B). Here, FGFR2 is linked to carcinoma.